Dr. Jianhua Zou, National University of Singapore, Singapore.
Dr. Jianhua Zou ๐จโโ๏ธ is a passionate biomedical researcher at the Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore ๐ธ๐ฌ. He specializes in photo-immunotherapy, nanomedicine, and cancer vaccine technologies ๐ฏ๐งซ. With over S$23 million in collaborative and principal investigator-led projects ๐ฐ, he leads innovative research into personalized treatment solutions. His expertise spans tumor-targeted therapies, mRNA delivery, and immune system enhancement ๐ง ๐. Dr. Zou is also recognized internationally for his contributions, having been an invited speaker at NIH, USA ๐๐ค, and celebrated for impactful essays and scientific leadership ๐
๐.
Publication Profiles
ย Education & Experienceย
๐ Education
-
๐งช Ph.D. in Chemistry
๐ Nanjing Tech University, China (2015.09โ2020.06)
๐จโ๐ซ Supervisor: Prof. Wei Huang (Academician of Chinese Academy of Sciences)
-
๐งซ Bachelor of Chemistry
๐ Changshu Institute of Technology, China (2011.09โ2015.06)
๐ฉโ๐ซ Supervisor: Prof. Qiaoyun Li
๐ผ Professional Experience
-
๐งฌ Research Fellow
๐ National University of Singapore, Singapore (2021.03โPresent)
๐จโ๐ซ Supervisor: Prof. Xiaoyuan Chen
-
๐งซ Postdoctoral Fellow
๐ National Institutes of Health (NIH), USA (2020.07โ2021.02)
๐จโโ๏ธ Supervisor: Dr. Richard Leapman (Director of NIBIB)
-
๐ฌ Visiting Scholar
๐ National Institutes of Health (NIH), USA (2018.11โ2020.06)
๐จโ๐ซ Supervisor: Dr. Xiaoyuan Chen
Summary Suitability For The Award
Dr. Jianhua Zou, a highly accomplished biomedical researcher based in Singapore, is a prime candidate for the Best Review Paper Award, owing to his extensive scholarly background, deep expertise in cancer immunotherapy, and ongoing contribution to high-impact review publications in nanomedicine and biotherapeutics. His multidisciplinary training, international research exposure, and active involvement in cutting-edge biomedical innovation provide a strong foundation for authoring insightful and transformative review articles.
ย Professional Development
Dr. Jianhua Zouโs professional journey is marked by high-level interdisciplinary collaboration and innovation ๐๐ฌ. He serves as Principal Investigator and collaborator on various national-level research projects funded by Singaporeโs Ministry of Health and National Research Foundation ๐ผ๐ก. His leadership in developing next-generation photosensitizers and therapeutic nanovaccines demonstrates his commitment to precision medicine ๐ฏ๐. Dr. Zou actively engages with the global scientific community through prestigious speaking invitations and research alliances ๐ค๐. His ongoing contributions are not only transforming cancer therapy but also enhancing immune-based interventions for broader clinical applications ๐ก๏ธ๐งช.
ย Research Focusย
Dr. Jianhua Zouโs research lies at the intersection of cancer immunotherapy, nanomedicine, and molecular diagnostics ๐งฌ๐งซ. His work focuses on engineering type I photosensitizers, mRNA-based nanocarriers, and targeted nanovaccines to enhance immune responses against complex diseases such as cancer and atherosclerosis ๐๐ฆ . Projects under his guidance explore innovative platforms like oral nanodrugs for microbiota modulation and site-specific delivery systems for tumors ๐ฏโ๏ธ. With a vision toward personalized medicine, his research brings together the latest in biomedical engineering, oncology, and pharmacology to design effective, non-invasive therapeutic strategies ๐๐ฌ.
Publication Top Noted
-
๐ Surface Modified Ti3C2 MXene Nanosheets for Tumor Targeting Photothermal/Photodynamic/Chemo Synergistic Therapy โ 630 citations, 2017
-
๐ก BODIPY derivatives for photodynamic therapy: influence of configuration versus heavy atom effect โ 254 citations, 2017
-
๐งฌ Solvent-assisted self-assembly of a metalโorganic framework based biocatalyst for cascade reaction driven photodynamic therapy โ 240 citations, 2020
-
๐ฌ Black phosphorus nanosheets immobilizing Ce6 for imaging-guided photothermal/photodynamic cancer therapy โ 232 citations, 2018
-
๐งช In situ polymerized hollow mesoporous organosilica biocatalysis nanoreactor for enhancing ROSโmediated anticancer therapy โ 192 citations, 2020
-
๐ A phototheranostic strategy to continuously deliver singlet oxygen in the dark and hypoxic tumor microenvironment โ 181 citations, 2020
-
๐ Photosensitizer synergistic effects: DโAโD structured organic molecule with enhanced fluorescence and singlet oxygen quantum yield for photodynamic therapy โ 155 citations, 2018
-
๐ฅ Penetration depth tunable BODIPY derivatives for pH triggered enhanced photothermal/photodynamic synergistic therapy โ 148 citations, 2019